Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 USD | -0.99% | +5.17% | +6.87% |
04-19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
04-01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
Sales 2024 * | 126M 173M | Sales 2025 * | 145M 199M | Capitalization | 201M 275M |
---|---|---|---|---|---|
Net income 2024 * | 6M 8.2M | Net income 2025 * | 18M 24.61M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.39 x |
P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
11.4
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | -0.45% | ||
1 week | +5.17% | ||
Current month | +24.58% | ||
1 month | +14.25% | ||
3 months | -5.77% | ||
6 months | -6.70% | ||
Current year | +6.87% |
Managers | Title | Age | Since |
---|---|---|---|
James Hall
CEO | Chief Executive Officer | 61 | 17-05-31 |
John Morberg
DFI | Director of Finance/CFO | 60 | 21-01-17 |
Steve Laninga
COO | Chief Operating Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 18-10-11 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 20-10-13 |
Katrina Houde
BRD | Director/Board Member | 66 | 19-08-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - | |
0.00% | 147 M€ | +4.88% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 6.615 | +0.30% | 4 973 |
24-04-26 | 6.595 | -0.68% | 110,906 |
24-04-25 | 6.64 | +4.90% | 256,407 |
24-04-24 | 6.33 | -1.86% | 105,089 |
24-04-23 | 6.45 | +2.54% | 136,987 |
Delayed Quote Nasdaq, April 29, 2024 at 10:04 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 201M | |
+26.84% | 661B | |
+27.35% | 566B | |
-6.35% | 352B | |
+20.44% | 332B | |
+2.65% | 283B | |
+13.94% | 231B | |
+5.20% | 200B | |
-9.04% | 195B | |
-4.79% | 145B |
- Stock Market
- Equities
- LFCR Stock